Project Coordinator Rare Diseases
|
Amsterdam or Brussels, NL
|
10 de abr. de 2025
|
5198
|
|
Senior Medical Science Liaison - AIR, West
|
Las Vegas, NV, US
|
10 de abr. de 2025
|
4623
|
|
Legal & Compliance Counsel
|
Brussels, BE
|
10 de abr. de 2025
|
3813
|
|
Access Value Partner - Zona Norte
|
Zona Norte, ES
|
10 de abr. de 2025
|
5200
|
|
Lead, Field Medical Team - AIR, US West
|
Cary, NC, US
|
9 de abr. de 2025
|
5165
|
|
Lead, Field Medical Team - AIR, US East
|
Cary, NC, US
|
9 de abr. de 2025
|
5166
|
|
GPV Operations Specialist/Manager CARE
|
Parma, IT
|
9 de abr. de 2025
|
5175
|
|
Corporate Supply Specialist
|
Parma, IT
|
9 de abr. de 2025
|
5267
|
|
Manager Regional Customer Team (all genders) Region Bremen
|
DE
|
9 de abr. de 2025
|
5190
|
|
Key Account Specialist
|
Warszawa, PL
|
8 de abr. de 2025
|
5324
|
|
Validation Engineer
|
Parma, IT
|
8 de abr. de 2025
|
5250
|
|
Environmental Specialist
|
Parma, IT
|
8 de abr. de 2025
|
5257
|
|
Key Account Specialist 1
|
Warszawa, PL
|
8 de abr. de 2025
|
5502
|
|
Key Account Specialist 1
|
Warszawa, PL
|
8 de abr. de 2025
|
5503
|
|
Medical Systems and Processes Lead, Global Rare Diseases (Contract)
|
Boston, MA, US
|
8 de abr. de 2025
|
5477
|
|
HCP Partner BU Respiratorio - Galicia
|
Galicia, ES
|
7 de abr. de 2025
|
4846
|
|
Manager, Regulatory Affairs Operations, Rare Diseases
|
Boston, MA, US
|
7 de abr. de 2025
|
5029
|
|
Operational Excellence Manager
|
Parma, IT
|
7 de abr. de 2025
|
5024
|
|
Pharmareferent Air (Respiratory Expert) (all genders) Region München
|
DE
|
7 de abr. de 2025
|
5369
|
|
Compliance Manager, Monitoring, Auditing & Risk
|
Cary, NC, US
|
6 de abr. de 2025
|
5181
|
|
Global Regulatory Affairs Quality Process Manager
|
Cary, NC, US
|
5 de abr. de 2025
|
5317
|
|
Project Coordinator - Brand Execution
|
Cary, NC, US
|
5 de abr. de 2025
|
5318
|
|
Global R&D QA, PV Auditor
|
Parma, IT
|
5 de abr. de 2025
|
5174
|
|
Access Value Partner - Levante
|
Levante, ES
|
5 de abr. de 2025
|
4997
|
|
Insights & Analytics Manager
|
Cary, NC, US
|
4 de abr. de 2025
|
5311
|
|